Chlortalidone/valsartan

Drug Profile

Chlortalidone/valsartan

Alternative Names: Valsartan/chlortalidone

Latest Information Update: 23 Feb 2016

Price : $50

At a glance

  • Originator Farma de Colombia
  • Class Antihypertensives; Branched-chain amino acids; Small molecules; Sulfonamides; Tetrazoles
  • Mechanism of Action Angiotensin type 1 receptor antagonists; Thiazide-like diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Hypertension

Most Recent Events

  • 23 Feb 2016 No recent reports on development identified - Phase-III for Hypertension in Ecuador and Colombia (PO)
  • 01 Apr 2013 Phase-III clinical trials in Hypertension in Colombia (PO)
  • 01 Apr 2013 Phase-III clinical trials in Hypertension in Ecuador (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top